Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 1/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KIT | P10721 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30584783 | 1.00 | CCR5 (0.53) | CCR5CHRM4MEN1KMT2ALMNA | |
| SCHEMBL30584743 | 0.92 | CCR5 (0.51) | CCR5CHRM4MEN1KMT2ALMNA | |
| SCHEMBL25433652 | 0.90 | CCR5 (0.51) | CCR5CHRM4MEN1KMT2ALMNA | |
| SCHEMBL25437981 | 0.90 | LMNA (0.59) | CCR5MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL31546339 | 0.87 | CCR5 (0.50) | CCR5MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL25439353 | 0.86 | MEN1 (0.53) | CCR5CHRM4MEN1KMT2ALMNA | |
| SCHEMBL30584865 | 0.86 | MEN1 (0.53) | CCR5CHRM4MEN1KMT2ALMNA | |
| SCHEMBL25439449 | 0.86 | CCR5 (0.49) | CCR5MEN1KMT2ALMNAKIT | |
| SCHEMBL31667355 | 0.86 | LMNA (0.58) | MEN1KMT2ALMNASMN1; SMN2MAPT | |
| SCHEMBL30584949 | 0.85 | MEN1 (0.49) | CCR5MEN1KMT2ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |